Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc

Eva Poveda, Vincent SorianoDepartment of Infectious Diseases, Hospital Carlos III, Madrid, SpainAbstract: Maraviroc is the first CCR5 antagonist approved for the treatment of HIV-1 infection. It specifically inhibits the replication of R5 viruses by blocking viral entry. HIV-1 tropism can be estimat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eva Poveda, Vincent Soriano
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/d00e38efa01d416dbaedef85485721bf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!